Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
PaperCitations, authors & open-access status
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2026 year and closed oa status.
1
Citations
2026
Year
closed
OA Status